FDA, Drug Cos. To Review Blood Thinner Plavix
The U.S. Food and Drug Administration has announced it is working with Sanofi-Aventis SA and Bristol-Myers Squibb Co. to examine the impact of other drugs and genetic factors on the effectiveness...To view the full article, register now.
Already a subscriber? Click here to view full article